Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed General Assembly
- Passed Senate
- To Governor
- Became Law
Overview
This bill classifies xylazine as a Schedule III controlled dangerous substance (CDS) under certain circumstances. Specifically, it allows the Director of the Division of Consumer Affairs to place xylazine in Schedule III if it has a potential for abuse less than Schedule I or II drugs, currently accepted medical use, and abuse could lead to moderate or low physical dependence or high psychological dependence. The bill also lists specific substances that would trigger this classification, including various xylazine derivatives and related compounds. It aims to combat the increasing presence of xylazine in illicit drugs and reduce overdose deaths.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Introduced
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours